Description: Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion. It also provides dry syrups, lyophilized vials, prefilled syringes, emulsion injection, and topicals. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.
Home Page: www.caplinpoint.net
Ashvich Tower
Chennai,
600096
India
Phone:
91 44 2496 8000
Officers
| Name | Title |
|---|---|
| Dr. Sridhar Ganesan | MD & Whole Time Director |
| Mr. D. Muralidharan | Chief Financial Officer |
| Mr. Partheeban Vivek Siddarth | Chief Operating officer |
| Mr. G. Venkatram | General Counsel, Company Secretary & Compliance Officer |
| Mr. M. Sathya Narayanan | Deputy Chief Financial Officer |
| Mr. Ashok Gorekey Partheeban | Head of Marketing - Latam Business |
| Mr. Thiagaraja Manikandan | Chief Transformation & Digital Officer |
Exchange: NSE
Country: IN : India
Currency: Indian Rupee (INR)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 36.3653 |
| Price-to-Book MRQ: | 7.0395 |
| Price-to-Sales TTM: | 9.7835 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 3406 |